[ad_1]
Retired General Paul Ostrovsky, who oversees the logistics of the US vaccine development initiative, said: "I am not concerned with our ability to purchase vaccines and bring them to the American people.".
But he added: "It appears that Incendios has developed plans with other countries, and many have been announced.".
Do many American officials, according to "Washington Post"They believe that supplies from other companies may not be enough to fill the gap in the need for a vaccine in the United States.
And last summer he urged "فايرز" US authorities wanted to buy 200 million doses of the vaccine, but authorities officials rejected the offer and only bought 100 million doses, according to sources familiar with the matter.
The newspaper said "The New York Times" Is the time "US authorities missed the opportunity to receive more vaccines"And officials justified the decision that the vaccine had not received approval from the Food and Drug Administration at the time.
No company received "Pfizer" Any government money to develop its vaccine, which means that Washington cannot influence its decisions compared to other companies.
“>
The newspaper added, citing sources familiar with the matter, that “this impossibility is due to the fact that other countries rushed to buy most of the quantities produced by the company or those it intends to produce in the coming months.”
He said supplying massive additional quantities of the vaccine could be possible in late June or July 2021.
This means that the US government may not be able to implement its aggressive vaccination program for most Americans until late spring and early summer.
The United States is the country most affected by the epidemic in the world and, with more than 15 million injured, it urgently needs the vaccine, which has proven its effectiveness.
The United States had previously announced the purchase of 100 million doses of the American “Pfizer” and the German “Biontech” vaccine, in the hope that it would help it intensify its efforts to contain the epidemic.
Officials of the administration of President Donald Trump denied the existence of problems related to the supply of the vaccine in the second quarter of 2021, talking about the presence of vaccines in development that may be added to the vaccine, “Pfizer” and “Biontech” .
However, others said that the problem with the availability of the vaccine is present.
“I am not concerned with our ability to buy vaccines and provide them to the American people,” said retired General Paul Ostrovsky, who oversees the logistics of the US vaccine development initiative.
But he added: “It is clear that Fires has developed plans with other countries, and many of them have been announced.”
However, many US officials, according to “The Washington Post,” believe that supplies from other companies may not be enough to fill the gap in the need for a vaccine in the United States.
Last summer, “Fires” urged US authorities to purchase 200 million doses of the vaccine, but authorities officials rejected the offer and only bought 100 million doses, according to sources familiar with the matter.
The “New York Times” newspaper said at the time that “the US authorities missed an opportunity to get more vaccines” and officials justified the decision that the vaccine had not received approval from the Food and Drug Administration at the time.
Pfizer has not received government funding to develop its vaccine, which means that Washington cannot influence its decisions compared to other companies.
[ad_2]
